Page last updated: 2024-10-16

4-hydroxybenzaldehyde and Parkinson Disease

4-hydroxybenzaldehyde has been researched along with Parkinson Disease in 2 studies

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kwon, J1
Hiep, NT1
Kim, DW1
Hong, S1
Guo, Y1
Hwang, BY1
Lee, HJ1
Mar, W1
Lee, D1
El-Sayed, HM1
El-Abassy, OM1
Abdellatef, HE1
Hendawy, HAM1
Ibrahim, H1

Other Studies

2 other studies available for 4-hydroxybenzaldehyde and Parkinson Disease

ArticleYear
Chemical Constituents Isolated from the Root Bark of Cudrania tricuspidata and Their Potential Neuroprotective Effects.
    Journal of natural products, 2016, 08-26, Volume: 79, Issue:8

    Topics: Animals; Cell Death; Disease Models, Animal; Glucose; Ischemia; Moraceae; Neuroprotective Agents; Nu

2016
Green Spectrophotometric Platforms for Resolving Overlapped Spectral Signals of Recently Approved Antiparkinsonian Drug (Safinamide) in the Presence of Its Synthetic Precursor (4-Hydroxybenzaldehyde): Applying Ecological Appraisal and Comparative Statisti
    Journal of AOAC International, 2022, Dec-22, Volume: 106, Issue:1

    Topics: Alanine; Antiparkinson Agents; Benzylamines; Humans; Parkinson Disease

2022